scholarly journals E05-06: Clinical staging of small cell lung cancer: report of the International Association for the Study of Lung Cancer Staging Initiative, Small Cell Lung Cancer Subcommittee

2007 ◽  
Vol 2 (8) ◽  
pp. S230-S231
Author(s):  
F.A. Shepherd ◽  
J Crowley ◽  
P Van Houtte ◽  
P.E. Postmus ◽  
D Carney ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
International Association ◽  
Cancer Staging ◽  
Small Cell ◽  
Clinical Staging ◽  
Small Cell Lung

scholarly journals Clinical and surgical-pathological staging in early non-small cell lung cancer

2013 ◽  
Vol 7 (1) ◽  
pp. 7
Author(s):  
Ioannis Koukis ◽  
Ioannis Gkiozos ◽  
Ioannis Ntanos ◽  
Elias Kainis ◽  
Konstantinos N. Syrigos
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
International Association ◽  
Critical Evaluation ◽  
Small Cell ◽  
Clinical Staging ◽  
Small Cell Lung ◽  
Non Invasive ◽  
Pathological Staging

Staging is of the utmost importance in the evaluation of a patient with non-small cell lung cancer (NSCLC) because it defines the actual extent of the disease. Accurate staging allows multidisciplinary oncology teams to plan the best surgical or medical treatment and to predict patient prognosis. Based on the recommendation of the International Association for the Study of Lung Cancer (IASLC), a tumor, node, and metastases (TNM) staging system is currently used for NSCLC. Clinical staging (c-TNM) is achieved via non-invasive modalities such as examination of case history, clinical assessment and radiological tests. Pathological staging (p-TNM) is based on histological examination of tissue specimens obtained with the aid of invasive techniques, either non-surgical or during the intervention. This review is a critical evaluation of the roles of current pre-operative staging modalities, both invasive and non-invasive. In particular, it focuses on new techniques and their role in providing accurate confirmation of patient TNM status. It also evaluates the surgical-pathological staging modalities used to obtain the true-pathological staging for NSCLC.

scholarly journals Clinical and surgical-pathological staging in early non-small cell lung cancer

2013 ◽  
pp. e7
Author(s):  
Ioannis Koukis ◽  
Ioannis Gkiozos ◽  
Ioannis Ntanos ◽  
Elias Kainis ◽  
Konstantinos N. Syrigos
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
International Association ◽  
Critical Evaluation ◽  
Small Cell ◽  
Clinical Staging ◽  
Small Cell Lung ◽  
Non Invasive ◽  
Pathological Staging

Staging is of the utmost importance in the evaluation of a patient with non-small cell lung cancer (NSCLC) because it defines the actual extent of the disease. Accurate staging allows multidisciplinary oncology teams to plan the best surgical or medical treatment and to predict patient prognosis. Based on the recommendation of the International Association for the Study of Lung Cancer (IASLC), a tumor, node, and metastases (TNM) staging system is currently used for NSCLC. Clinical staging (c-TNM) is achieved via non-invasive modalities such as examination of case history, clinical assessment and radiological tests. Pathological staging (p-TNM) is based on histological examination of tissue specimens obtained with the aid of invasive techniques, either non-surgical or during the intervention. This review is a critical evaluation of the roles of current pre-operative staging modalities, both invasive and non-invasive. In particular, it focuses on new techniques and their role in providing accurate confirmation of patient TNM status. It also evaluates the surgical-pathological staging modalities used to obtain the true-pathological staging for NSCLC.

scholarly journals C2-06: Integrated PET/CT versus 3T whole body MR imaging: efficacy comparison in non-small cell lung cancer staging

2007 ◽  
Vol 2 (8) ◽  
pp. S363-S364
Author(s):  
Kyung-Min Shin ◽  
Chin A. Yi ◽  
Kyung Soo Lee ◽  
Byung-Tae Kim ◽  
Hojoong Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Mr Imaging ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Cancer Staging ◽  
Small Cell ◽  
Whole Body ◽  
Small Cell Lung ◽  
Pet Ct

scholarly journals Unification of T2a and T2b Tumors to T2 Tumors in Non-Small Cell Lung Cancer Staging

2011 ◽  
Vol 17 (6) ◽  
pp. 559-564
Author(s):  
Shuji Haraguchi ◽  
Kiyoshi Koizumi ◽  
Hirohiko Akiyama ◽  
Iwao Mikami ◽  
Daisuke Okada ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Cancer Staging ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document